Adolescents may have immature hepatic metabolic enzymes (such as CYP3A4), leading to the accumulation of the active metabolite (N-desmethyl loperamide), which can exacerbate QTc interval prolongation and the risk of TdP through hERG potassium channel inhibition. The gene discussed is KCNA3; the disease is torsades de pointes.